Navigation Links
IntraMed Diagnostics Announces Two Senior-Level Additions
Date:5/15/2013

Boulder, Colo. (PRWEB) May 15, 2013

IntraMed Diagnostics, LLC, a subsidiary of Express Diagnostics Int’l (EDI), is pleased to welcome Dean Kingston as director of engineering and manufacturing and Barry Vant-Hull, Ph.D., as senior software engineer.

Kingston to serve as director of engineering and manufacturing

Kingston previously served as engineering manager and senior product development engineer for Eveia Medical, Inc. While with Eveia Medical, he led the design, research, and development of the ArcFlow™ Point-of-Care platform, designed to be implemented in a variety of quantitative tests, including devices intended for testing coagulation rates (blood thinners), C-reactive protein (CRP), HbA1c, and several other potential clinical diagnostics applications.

Eveia’s patent pending cell quantitation technology will also be incorporated into EDI’s AnemiaCheck™ POC Quantitative Hematocrit Test, which will be available for export in Q3 2013. IntraMed Diagnostics recently acquired an option for future development of Eveia Medical’s complete portfolio of point-of-care clinical diagnostic testing assets.

Kingston began his career at B-Ten Systems, Inc., designing robotic assembly machines for medical industries. The company specializes in custom automation, robotics, and machine design manufacturing. As vice president of engineering, Kingston led many high-profile projects, implemented Pro/Engineer® design software with Pro/Intralink® data storage, and established a quality assurance system, design controls, and design standards. He later joined the executive team of Bolt Industries, Inc., where he served as general manager of the company’s Minnesota facility.

“Dean will be key to bringing our innovative testing devices to market. His design and manufacturing skills will help to ensure robust test performance in the field, while maintaining designs that can be manufactured on efficient, fully-automated lines,” says Steve Tyrrell, EDI and IntraMed vice president of research and development. “Having been a part of the team since the inception of the technologies, Dean’s experience will be important as we develop and introduce additional applications to market.”

Kingston is a graduate of Colorado State University, where he earned a degree in mechanical engineering with an emphasis in product design and manufacturing.

Vant-Hull directing integration of software with onsite testing platforms

Dr. Vant-Hull is the former director of research and development at Eveia Medical. During his tenure he was responsible for developing hardware and software to support a new in vitro diagnostics platform for clinical laboratories. Additionally, he has an extensive background in software development, including laboratory automation, high-throughput screening robotic workstations, and development of a tiered Java-based framework for integrating third-party and in-house devices for automating laboratory protocols.

“Dr. Vant-Hull brings the valuable combination of strong software development skills and a sound understanding of science and mathematics. These skills will enable us to develop innovative software applications that are easy to use, while applying advanced algorithms that enhance the performance of associated testing devices,” says Tyrrell. “We look forward to benefitting from Dr. Vant-Hull’s extensive background in biochemistry, engineering, and software development as we further develop our onsite diagnostic technologies.”

During his postdoctoral research at the University of Colorado, Dr. Vant-Hull assisted in biochemical engineering and molecular biology while studying high-density hybridoma cultures in bioreactors. He holds a doctorate in biochemical engineering and a masters of science from the University of Colorado.

Both Kingston and Vant-Hull are based out of the IntraMed Diagnostics facility in Boulder, Colo.

About IntraMed Diagnostics, LLC
IntraMed Diagnostics, LLC, a subsidiary of Express Diagnostics Int’l, Inc., was established to increase market penetration in the point-of-care testing market, a rapidly expanding multi-billion dollar industry. The company conducts engineering, research, and development for onsite in vitro diagnostic drugs of abuse screening and health diagnostics applications. Learn more at intrameddx.com.

About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of health screening devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10732936.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConference Live Lands CMO of Roche Diagnostics and Other High Level Speakers
2. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
3. TrueVision® 3D Surgical and i-Optics Announce Collaboration to Integrate Diagnostics and Computer-Guidance in Cataract Surgery
4. Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing
5. Advanced Animal Diagnostics Raises $6 Million for On-farm Diagnostics
6. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
7. MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program
8. Dominion Diagnostics to Sponsor 2013 Addiction Professional Panel Series as Thought Leadership Partner
9. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
10. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
11. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):